l Blockers: Dihydropyridines (e.g., nifedipine) may be dosed from 3. 30 to 90 mg daily depending on formulation. Such variability necessitates individualized dosing adjustments based on patient factors such as renal function and comorbidities. Pharmacokinetics and Dosing Considerations Dosing re
cts. Rather than focusing solely on the chemical structure, this classification emphasizes how drugs influence physiological functions or treat specific diseases. KD Tripathi’s classification stands out because it balances both pharmacodynamics (drug action) and pharmacotherape
’s system facilitates quick decision-making in clinical settings. For example, when managing hypertension, one can refer directly to the cardiovascular drugs section and explore options such as ACE inhibitors, beta-blockers, or calci
ut understanding how drugs produce their effects. These mechanisms can be categorized into: Receptor Binding: Drugs interact with specific receptors to modulate physiological responses. Enzyme Inhibition or Activation: Drugs alter enzyme activity, affecting metabolic pathways
